GeneJet Biotech Co. Ltd.

Tissuemed is a well-established medical device technology company based in Leeds, UK. With a reputation for scientific innovation that goes back over twenty years, the company focuses on the development, manufacture and commercialisation of advanced surgical sealants. At the core of Tissuemed’s activities is the TissuePatch™ product family, the result of almost twenty years’ ongoing research and development. TissuePatch surgical films are designed to help clinicians of different specialities to seal sutured or stapled tissues against leakage of air, blood and other fluids, including Cerebrospinal Fluid (CSF).

BioTissue is the leader in innovative technologies using products derived from human amniotic membrane tissues. In 1997, BioTissue was the first company to introduce the use of cryopreserved amniotic membrane tissue for clinical application, by utilizing its proprietary CryoTek technology, proven to preserve the innate biological and structural properties of the amniotic membrane tissue. By adopting the BioTissue name across the entire organization, the company will also reflect that innovative heritage and promise in its surgical business, which was previously known as Amniox Medical. BioTissue is pursuing FDA approval through submission of a Biologics License Applications (BLA) for some of our products as evidenced in a recently published Phase 2 study for complex diabetic foot ulcers.20 Our company will continue to provide sustainable health economic value, solve unmet clinical needs, and lead in technological innovation in seeking to deliver the promise of regenerative healing for our physicians and patients. Our extensive research allows us to preserve and deliver the most functional allograft for your needs. We empower healthcare professionals to deliver optimal patient healing outcomes, setting the standards that define next-generation care. TissueTech was founded in 2001 as the parent entity for BioTissue Inc., which develops and markets regenerative therapies for treating the ocular surface. In 2011, our company expanded from ocular space and its product offerings that, include Prokera®, AmnioGraft® and AmnioGuard® to additional market segments such as orthopedics,14-16 neuropathy,17 wound care,18-23 spine,24 urology25, and pain management26,27 using the same birth tissue products processed using our patented manufacturing technology.

TissueForm improves life for people affected by volumetric tissue loss by harnessing the natural, restorative power of extracellular matrix to correct and repair defects or injuries with a novel, regenerative biomaterial. Our core technology combines a natural tissue powder and biocompatible gel for stabilized crosslinking at human body temperature. Our biomaterial fills volumetric defects, integrates with host tissue, and promotes healing.

Sutures can cut through otherwise intact tissue due to the presence of a sharp leading edge - described as "suture pull-through" or "cheese-wiring" - leading to repair failure. It is the world's only device that both approximates tissue and permits ingrowth for a stronger, earlier repair.3. Duramesh™ is the only wound closure device that minimizes the concentration of tension at the suture-tissue interface and facilitates tissue integration to help surgeons close tissue defects securely and confidently. Sutures can cut through otherwise intact tissue due to the presence of a sharp leading edge - described as "suture pull-through" or "cheese-wiring" leading to repair failure.

Premium cotton/spandex fabric (latex free) with a water based acrylic adhesive. Active Ingredients (AIs) are suspended in a proprietary matrix that releases the AIs when you need them most. The backing is made of easily cut materials for accurate dosages and desired lengths. Highest quality supplements & herbs selected to create these effective formulations. Tape like a pro after a couple applications!

BioTissue, a double spin-off of the Charité University Hospital in Berlin and the University Hospital in Freiburg, is the pioneer par excellence in the field of regenerative medicine and tissue engineering. BioTissue’s technology platform offers unique solutions to improve quality of life by intelligently harnessing the body’s own regenerative potential through implants that can be applied with minimally invasive surgical procedures. BioTissue has focused on two areas of regenerative medicine to offer orthobiological solutions for cartilage defects:. This innovative field of advanced biomedical technologies provides therapies to regenerate damaged tissues or organs. In order to continuously expand our technological lead, we have founded our own development company.